Does Invega (paliperidone) come in a 4 mg strength?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Invega Does Not Come in 4 mg

No, Invega (paliperidone) extended-release tablets do not come in a 4 mg strength. According to the FDA prescribing information, Invega is available only in 1.5 mg (orange-brown), 3 mg (white), 6 mg (beige), and 9 mg (pink) strengths 1.

Available Strengths

The four available tablet strengths are:

  • 1.5 mg - orange-brown capsule-shaped tablet marked "PAL 1.5"
  • 3 mg - white capsule-shaped tablet marked "PAL 3"
  • 6 mg - beige capsule-shaped tablet marked "PAL 6"
  • 9 mg - pink capsule-shaped tablet marked "PAL 9"

All tablets use OROS® osmotic drug-release technology for once-daily extended-release dosing 1.

Clinical Implications

If you need a dose between 3 mg and 6 mg, you cannot achieve exactly 4 mg with Invega tablets. The tablets cannot be split, crushed, or chewed due to their extended-release delivery system design 1. The osmotic pump mechanism requires the tablet to remain intact to function properly.

For dosing, you must select from the available strengths (1.5,3,6, or 9 mg). The recommended therapeutic dose range is 3-12 mg once daily, with 6 mg being a common starting dose for many patients 2, 3.

References

2
Research

Paliperidone ER: a review of the clinical trial data.

Neuropsychiatric disease and treatment, 2007

Related Questions

What strengths does Invega (paliperidone) come in?
How quickly can the dose of Invega (paliperidone) be increased?
How should I administer 6 mg of Invega (paliperidone) and what monitoring and dose adjustments are required?
What are the available formulations of Invega (paliperidone) and their approved indications?
What is the oral formulation of Invega Sustenna (paliperidone)?
How should an acute facial rash with burning and peeling that develops during an ear infection be evaluated and managed?
What is the recommended treatment for a patient who develops facial and neck erythema, pruritus, burning, and desquamation following a Group A streptococcal infection?
What is the appropriate treatment for a patient with hypercalcemia (serum calcium 11.2 mg/dL) and poorly controlled diabetes (HbA1c 9.1%)?
What is the recommended evaluation and management for a patient presenting with generalized aches and fever suggestive of influenza?
Is chamomile classified as an adaptogen?
What is the significance of a urine microalbumin level of 31 mg/L and how should it be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.